<qa>  How many hours will each patient receive?BPM31510 Nanosuspension Injection 40 mgmL will be administered IV over 144 hours. Each patient will receive 2 consecutive 72-hour infusions per week Tuesday-Friday and Friday-Monday. Patients enrolled in the monotherapy arm will receive a BPM31510 dose of 171 mgKg. The dose for BPM31510 in the combination arm is 110 mgKg. Patients enrolled in the combination therapy arm will also be treated with gemcitabine IV once weekly starting at week 3 at a starting dose of 1000 mgm2. 